Quick Answer
Amneal Pharmaceuticals, Inc. reported Stockholders Equity of -$70.79 million for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$70.79M | +35.2% |
| 2024 | -$109.27M | -652.4% |
| 2023 | $19.78M | -93.4% |
| 2022 | $298.42M | -17.2% |
| 2021 | $360.34M | +18.8% |
| 2020 | $303.27M | +30.7% |
| 2019 | $232.01M | -54.0% |
| 2018 | $504.75M | — |
| 2017 | $0.00 | — |
| 2017 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$109.46M | -17.2% | +2.4% |
| June 30, 2025 | -$112.12M | -95.1% | +14.8% |
| March 31, 2025 | -$131.67M | -106.6% | -20.5% |
| December 31, 2024 | -$109.27M | -652.4% | -16.9% |
| September 30, 2024 | -$93.43M | -128.2% | -62.6% |
| June 30, 2024 | -$57.47M | -118.1% | +9.8% |
| March 31, 2024 | -$63.72M | -121.6% | -422.1% |
| December 31, 2023 | $19.78M | -93.4% | -94.0% |
- Amneal Pharmaceuticals, Inc. showed an increase of +35.2% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: